ATE515576T1 - Protein c polymorphismen - Google Patents

Protein c polymorphismen

Info

Publication number
ATE515576T1
ATE515576T1 AT03727058T AT03727058T ATE515576T1 AT E515576 T1 ATE515576 T1 AT E515576T1 AT 03727058 T AT03727058 T AT 03727058T AT 03727058 T AT03727058 T AT 03727058T AT E515576 T1 ATE515576 T1 AT E515576T1
Authority
AT
Austria
Prior art keywords
patient
protein
inflammatory condition
polymorphisms
polymorphism
Prior art date
Application number
AT03727058T
Other languages
English (en)
Inventor
James Russell
Keith Walley
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE515576T1 publication Critical patent/ATE515576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT03727058T 2002-05-28 2003-05-28 Protein c polymorphismen ATE515576T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38312802P 2002-05-28 2002-05-28
PCT/CA2003/000751 WO2003100090A2 (en) 2002-05-28 2003-05-28 Protein c polymorphisms

Publications (1)

Publication Number Publication Date
ATE515576T1 true ATE515576T1 (de) 2011-07-15

Family

ID=29584509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727058T ATE515576T1 (de) 2002-05-28 2003-05-28 Protein c polymorphismen

Country Status (7)

Country Link
US (2) US7820376B2 (de)
EP (1) EP1507872B1 (de)
JP (2) JP2005527218A (de)
AT (1) ATE515576T1 (de)
AU (1) AU2003233292A1 (de)
CA (1) CA2487106A1 (de)
WO (1) WO2003100090A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219473A1 (en) * 2004-03-04 2005-09-15 The University Of British Columbia Toll-like receptor 2 (TLR-2) haplotypes predict outcome of patients
JP2007525980A (ja) * 2004-03-04 2007-09-13 ザ ユニバーシティ オブ ブリティッシュ コロンビア 患者結果を予測するトロンボモジュリン（ｔｈｂｄ）ハプロタイプ
CA2479968A1 (en) * 2004-09-01 2006-03-01 Keith R. Walley Protein c and endothelial protein c receptor polymorphisms as indicators of patient outcome
MX2008009056A (es) * 2006-01-12 2009-01-07 Univ British Columbia Polimorfismos asociados con la trayectoria de la proteina c como predictores de la respuesta a la administracion de la proteina c activada a un compuesto similar a la proteina.
CN101688327A (zh) * 2007-02-16 2010-03-31 不列颠哥伦比亚大学 Serpine1多态性预测对活化蛋白c给药的应答和死亡风险
US20110092446A1 (en) * 2007-07-20 2011-04-21 Cedric Francois Compositions and methods for treatment of trauma

Also Published As

Publication number Publication date
AU2003233292A8 (en) 2003-12-12
CA2487106A1 (en) 2003-12-04
AU2003233292A1 (en) 2003-12-12
JP2010142252A (ja) 2010-07-01
WO2003100090A2 (en) 2003-12-04
WO2003100090A3 (en) 2004-04-08
EP1507872B1 (de) 2011-07-06
US20070128594A1 (en) 2007-06-07
US20110020825A1 (en) 2011-01-27
EP1507872A2 (de) 2005-02-23
JP2005527218A (ja) 2005-09-15
US7820376B2 (en) 2010-10-26

Similar Documents

Publication Publication Date Title
Cuyvers et al. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
DK1071710T4 (da) Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markører deri og fremgangsmåder til påvisning af astma
CA2735578C (en) Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
ATE462710T1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
DK1520039T3 (da) Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose
WO2008063479A3 (en) Pancreatic cancer biomarkers
WO2005098445A3 (en) Lung cancer biomarkers
Lomax-Browne et al. IgA1 glycosylation is heritable in healthy twins
ATE515576T1 (de) Protein c polymorphismen
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
DK1529116T3 (da) Fremgangsmåde til forudsigelse af respons på behandling med rivastigmin baseret på ApoE-genotypen hos demenspatienter
CY1111970T1 (el) Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ
WO2007086980A3 (en) Methods of determining the risk of developing coronary artery disease
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
WO2009033282A8 (en) Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
WO2008048902A8 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
TW200801200A (en) Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist
ATE466104T1 (de) Als indikatoren zur patientenprognose geeignete haplotypen von plasminogenaktivator-inhibitor-1 (pai-1)
WO2006002930A3 (en) FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS
WO2020230133A8 (en) Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
MXPA05009162A (es) Metodos para determinar un regimen quimioterapeutico basado en la perdida de heterocigosidad en la posicion de sintasa de timidilato.
WO2002004683A3 (en) Method of detecting an increased susceptibility to breast cancer
WO2006053955A3 (en) Method and kit for detecting a risk of essential arterial hypertension
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties